Because the expression of EGFR pathway members was progressively lost with less differentiated tumor cells, we asked whether this trend would be more pronounced among invasive tumors, i.e., those unresectable tumors that required liver transplantation and/or were metastatic, within each tumor cell type. Here, EGFR is linked to neoplasm.